Your browser doesn't support javascript.
loading
STROBE-metagenomics: a STROBE extension statement to guide the reporting of metagenomics studies.
Bharucha, Tehmina; Oeser, Clarissa; Balloux, Francois; Brown, Julianne R; Carbo, Ellen C; Charlett, Andre; Chiu, Charles Y; Claas, Eric C J; de Goffau, Marcus C; de Vries, Jutte J C; Eloit, Marc; Hopkins, Susan; Huggett, Jim F; MacCannell, Duncan; Morfopoulou, Sofia; Nath, Avindra; O'Sullivan, Denise M; Reoma, Lauren B; Shaw, Liam P; Sidorov, Igor; Simner, Patricia J; Van Tan, Le; Thomson, Emma C; van Dorp, Lucy; Wilson, Michael R; Breuer, Judith; Field, Nigel.
Affiliation
  • Bharucha T; Department of Biochemistry, University of Oxford, Oxford, UK; Lao-Oxford-Mahosot Hospital-Wellcome Trust Research Unit, Microbiology Laboratory, Mahosot Hospital, Vientiane, Laos. Electronic address: t.bharucha@doctors.org.uk.
  • Oeser C; Centre for Molecular Epidemiology and Translational Research, University College London, London, UK.
  • Balloux F; UCL Genetics Institute, University College London, London, UK.
  • Brown JR; Microbiology, Virology and Infection Prevention and Control, Great Ormond Street Hospital for Children, London, UK.
  • Carbo EC; Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands.
  • Charlett A; Statistics, Modelling and Economics Department, Public Health England, London, UK.
  • Chiu CY; Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA, USA.
  • Claas ECJ; Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands.
  • de Goffau MC; Wellcome Sanger Institute, Hinxton, UK; Department of Veterinary Medicine, University of Cambridge, Cambridge, UK.
  • de Vries JJC; Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands.
  • Eloit M; Pathogen Discovery Laboratory, Institut Pasteur, Paris, France.
  • Hopkins S; Healthcare-Associated Infection and Antimicrobial Resistance, Public Health England, London, UK; Infectious Diseases Unit, Royal Free Hospital, London, UK.
  • Huggett JF; National Measurement Laboratory, LGC, Teddington, UK; School of Biosciences & Medicine, Faculty of Health & Medical Sciences, University of Surrey, Guildford, UK.
  • MacCannell D; Office of Advanced Molecular Detection, Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Morfopoulou S; Division of Infection and Immunity, University College London, London, UK.
  • Nath A; Section of Infections of the Nervous System, National Institutes of Health, Bethesda, MD, USA.
  • O'Sullivan DM; National Measurement Laboratory, LGC, Teddington, UK.
  • Reoma LB; Section of Infections of the Nervous System, National Institutes of Health, Bethesda, MD, USA.
  • Shaw LP; Nuffield Department of Medicine, University of Oxford, Oxford, UK.
  • Sidorov I; Department of Medical Microbiology, Leiden University Medical Center, Leiden, Netherlands.
  • Simner PJ; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
  • Van Tan L; Emerging Infections Group, Oxford University Clinical Research Unit, Ho Chi Minh city, Vietnam.
  • Thomson EC; MRC-University of Glasgow Centre for Virus Research, University of Glasgow, Glasgow, UK.
  • van Dorp L; UCL Genetics Institute, University College London, London, UK.
  • Wilson MR; Weill Institute for Neurosciences and Department of Neurology, University of California, San Francisco, CA, USA.
  • Breuer J; Division of Infection and Immunity, University College London, London, UK; Great Ormond Street Hospital for Children, London, UK.
  • Field N; Centre for Molecular Epidemiology and Translational Research, University College London, London, UK.
Lancet Infect Dis ; 20(10): e251-e260, 2020 10.
Article in En | MEDLINE | ID: mdl-32768390
The term metagenomics refers to the use of sequencing methods to simultaneously identify genomic material from all organisms present in a sample, with the advantage of greater taxonomic resolution than culture or other methods. Applications include pathogen detection and discovery, species characterisation, antimicrobial resistance detection, virulence profiling, and study of the microbiome and microecological factors affecting health. However, metagenomics involves complex and multistep processes and there are important technical and methodological challenges that require careful consideration to support valid inference. We co-ordinated a multidisciplinary, international expert group to establish reporting guidelines that address specimen processing, nucleic acid extraction, sequencing platforms, bioinformatics considerations, quality assurance, limits of detection, power and sample size, confirmatory testing, causality criteria, cost, and ethical issues. The guidance recognises that metagenomics research requires pragmatism and caution in interpretation, and that this field is rapidly evolving.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metagenomics Type of study: Prognostic_studies Aspects: Ethics Limits: Humans Language: En Journal: Lancet Infect Dis Year: 2020 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Metagenomics Type of study: Prognostic_studies Aspects: Ethics Limits: Humans Language: En Journal: Lancet Infect Dis Year: 2020 Document type: Article